RAC 1.11% $1.83 race oncology ltd

Ann: Race Leadership Changes, page-279

  1. 266 Posts.
    lightbulb Created with Sketch. 1032
    Yes, good reminder Patch for shareholders trying to value Zantrene to refer to this post by Dr T back in July 2022 and the price points and financial motivations of US Oncologists to consider using a Zantrene-Doxorubicin co-formulation in preference to Dox alone.

    In short, you are massively undervaluing the true value of Zantrene in Cardioprotection at $500/dose.

    https://hotcopper.com.au/data/attachments/5151/5151024-dc45817701834b8d7e2007eb57d1f252.jpg


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.